info@accelevir.com
Start Your Project
About Us
Team
Collaborators
Services
Molecular & Genomic Analysis
Digital PCR / qPCR Assay Development & Validation
Pre-Validated AAV & Lentiviral Vector Assays
Biodistribution Studies
Targeted Short- & Long-Read Sequencing
Viral Load & Variant Discovery Assays
Functional Immunology & Cellular Assays
PBMC isolation & cryopreservation
Multiparameter flow cytometry (custom panels)
ELISpot / FluoroSpot / ICS
Cytokine multiplex (Luminex, ELISA)
Cytolytic function assays (T, B, NK cells)
Cell proliferation assays
Dendritic Cell Activation
Ex Vivo MoA and Efficacy Assays / PK Assays
Innate & Adaptive Response Modeling
Longitudinal Immune Monitoring
Integrated Virology-Immunology Workflows
Infectious Sample Processing (BSL-2+)
Low-Input Workflows
Multi-Species Assay Capability
Combined Genotypic & Phenotypic Readouts
Regulatory & Quality Support
CLIA-Certified Laboratory
GLP/GCP-Compliant Workflows
Fit-for-Purpose Biomarker Development
Companion Diagnostic (CDx) Assay Support
Industry Solutions
Cell and Gene Therapy Services
Immuno-Oncology
Immune Response Profiling (ICS, ELISpot, Cytokine Multiplex)
CRS Risk Monitoring for Cell Therapies
Tumor Antigen-Specific Immune Monitoring
Infectious Diseases
HIV, HBV, HDV, Influenza, RSV, emerging pathogen assays
Ultrasensitive Viral Load and Reservoir Assays
Vaccine Immunogenicity Monitoring
Viral Persistence Models
Neutralization Assays
PBMC Assays
CRO & CDMO Partnerships
Integrated Molecular + Immune Endpoints
Subcontract Specialty Biomarker Assays
Rapid Onboarding & Flexible Scaling
In Vivo Partnerships
Academic & Government Programs
Investigator-Initiated Trial Support
NIH / CEPI / BARDA Program Capabilities
Translational Biomarker Development
Therapeutic Modalities
AAV Gene Therapy
Lentiviral Vector Therapies
Cell & Stem Cell Therapies
CRISPR & Gene Editing
mRNA Therapies & Vaccines
Oncolytic Viruses
Antibody & Bispecific Therapeutics
siRNA & Antisense Oligonucleotides (ASOs)
HIV Services
Academic & Non-Profit
News Room
Publications
Contact Us
Author:
adminacc
Sorry, no posts matched your criteria.
Accelevir | © 2023
